{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T05:03:56Z","timestamp":1781327036807,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,11,25]],"date-time":"2015-11-25T00:00:00Z","timestamp":1448409600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Regional Clinical Research Department"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s00592-015-0820-2","type":"journal-article","created":{"date-parts":[[2015,11,25]],"date-time":"2015-11-25T00:18:26Z","timestamp":1448410706000},"page":"469-475","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["RAGE and CYBA polymorphisms are associated with microalbuminuria and end-stage renal disease onset in a cohort of type 1 diabetes mellitus patients over a 20-year follow-up"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9945-9919","authenticated-orcid":false,"given":"Benoit","family":"Franko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Yves","family":"Benhamou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Genty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Jouve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Nasse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Rzeoecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Semeraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Jos\u00e9","family":"Stasia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Zaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,25]]},"reference":[{"key":"820_CR1","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1681\/ASN.2010040354","volume":"22","author":"ET Rosolowsky","year":"2011","unstructured":"Rosolowsky ET, Skupien J, Smiles AM et al (2011) Risk for ESRD in Type 1 diabetes remains high despite renoprotection. J Am Soc Nephrol 22:545\u2013553. doi: 10.1681\/ASN.2010040354","journal-title":"J Am Soc Nephrol"},{"key":"820_CR2","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0272-6386(99)70035-1","volume":"34","author":"E Ritz","year":"1999","unstructured":"Ritz E, Rychl\u00edk I, Locatelli F, Halimi S (1999) End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions. Am J Kidney Dis Off J Natl Kidney Found 34:795\u2013808. doi: 10.1016\/S0272-6386(99)70035-1","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"key":"820_CR3","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00592-014-0603-1","volume":"51","author":"F D\u2019Addio","year":"2014","unstructured":"D\u2019Addio F, Trevisani A, Ben Nasr M et al (2014) Harnessing the immunological properties of stem cells as a therapeutic option for diabetic nephropathy. Acta Diabetol 51:897\u2013904. doi: 10.1007\/s00592-014-0603-1","journal-title":"Acta Diabetol"},{"key":"820_CR4","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.semnephrol.2012.07.006","volume":"32","author":"A Doria","year":"2012","unstructured":"Doria A, Niewczas MA, Fiorina P (2012) Can existing drugs approved for other indications retard renal function decline in patients with type 1 diabetes and nephropathy? Semin Nephrol 32:437\u2013444. doi: 10.1016\/j.semnephrol.2012.07.006","journal-title":"Semin Nephrol"},{"key":"820_CR5","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","volume":"414","author":"M Brownlee","year":"2001","unstructured":"Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813\u2013820. doi: 10.1038\/414813a","journal-title":"Nature"},{"key":"820_CR6","doi-asserted-by":"crossref","first-page":"460","DOI":"10.2337\/db07-1119","volume":"57","author":"V Thallas-Bonke","year":"2008","unstructured":"Thallas-Bonke V, Thorpe SR, Coughlan MT et al (2008) Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway. Diabetes 57:460\u2013469. doi: 10.2337\/db07-1119","journal-title":"Diabetes"},{"issue":"Suppl 1","key":"820_CR7","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.diabres.2008.09.017","volume":"82","author":"H Ha","year":"2008","unstructured":"Ha H, Hwang I-A, Park JH, Lee HB (2008) Role of reactive oxygen species in the pathogenesis of diabetic nephropathy. Diabetes Res Clin Pract 82(Suppl 1):S42\u2013S45. doi: 10.1016\/j.diabres.2008.09.017","journal-title":"Diabetes Res Clin Pract"},{"key":"820_CR8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1152\/physrev.00044.2005","volume":"87","author":"K Bedard","year":"2007","unstructured":"Bedard K, Krause K-H (2007) The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87:245\u2013313. doi: 10.1152\/physrev.00044.2005","journal-title":"Physiol Rev"},{"key":"820_CR9","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.freeradbiomed.2012.06.027","volume":"53","author":"A Babelova","year":"2012","unstructured":"Babelova A, Avaniadi D, Jung O et al (2012) Role of Nox4 in murine models of kidney disease. Free Radic Biol Med 53:842\u2013853. doi: 10.1016\/j.freeradbiomed.2012.06.027","journal-title":"Free Radic Biol Med"},{"key":"820_CR10","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.2337\/diacare.26.11.3111","volume":"26","author":"AD Hodgkinson","year":"2003","unstructured":"Hodgkinson AD, Millward BA, Demaine AG (2003) Association of the p22phox component of NAD(P)H oxidase with susceptibility to diabetic nephropathy in patients with type 1 diabetes. Diabetes Care 26:3111\u20133115","journal-title":"Diabetes Care"},{"key":"820_CR11","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/j.thromres.2010.01.001","volume":"125","author":"S Fang","year":"2010","unstructured":"Fang S, Wang L, Jia C (2010) Association of p22phox gene C242T polymorphism with coronary artery disease: a meta-analysis. Thromb Res 125:e197\u2013e201. doi: 10.1016\/j.thromres.2010.01.001","journal-title":"Thromb Res"},{"key":"820_CR12","first-page":"297","volume":"65","author":"Y Ishibashi","year":"2012","unstructured":"Ishibashi Y, Matsui T, Takeuchi M, Yamagishi S (2012) Beneficial effects of metformin and irbesartan on advanced glycation end products (AGEs)-RAGE-induced proximal tubular cell injury. Pharmacol Res Off J Ital Pharmacol Soc 65:297\u2013302. doi: 10.1016\/j.phrs.2011.11.001","journal-title":"Pharmacol Res Off J Ital Pharmacol Soc"},{"key":"820_CR13","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S0002-9440(10)63909-0","volume":"162","author":"TM Wendt","year":"2003","unstructured":"Wendt TM, Tanji N, Guo J et al (2003) RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy. Am J Pathol 162:1123\u20131137. doi: 10.1016\/S0002-9440(10)63909-0","journal-title":"Am J Pathol"},{"key":"820_CR14","author":"B Franko","year":"2014","unstructured":"Franko B, Brault J, Jouve T et al (2014) Differential impact of glucose levels and advanced glycation end-products on tubular cell viability and pro-inflammatory\/profibrotic functions. Biochem Biophys Res Commun. doi: 10.1016\/j.bbrc.2014.08.042","journal-title":"Biochem Biophys Res Commun"},{"key":"820_CR15","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.2337\/diabetes.50.6.1505","volume":"50","author":"BI Hudson","year":"2001","unstructured":"Hudson BI, Stickland MH, Futers TS, Grant PJ (2001) Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy. Diabetes 50:1505\u20131511","journal-title":"Diabetes"},{"key":"820_CR16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2337\/diacare.27.2.303","volume":"27","author":"S Matsunaga-Irie","year":"2004","unstructured":"Matsunaga-Irie S, Maruyama T, Yamamoto Y et al (2004) Relation between development of nephropathy and the p22phox C242T and receptor for advanced glycation end product G1704T gene polymorphisms in type 2 diabetic patients. Diabetes Care 27:303\u2013307","journal-title":"Diabetes Care"},{"key":"820_CR17","first-page":"733","volume":"18","author":"KG Santos","year":"2005","unstructured":"Santos KG, Canani LH, Gross JL et al (2005) Relationship of p22phox C242T polymorphism with nephropathy in type 2 diabetic patients. J Nephrol 18:733\u2013738","journal-title":"J Nephrol"},{"key":"820_CR18","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jns.2013.04.022","volume":"330","author":"L Gu","year":"2013","unstructured":"Gu L, Su L, Liang B et al (2013) Association between the C242T polymorphism of p22phox gene and ischemic stroke: a meta-analysis. J Neurol Sci 330:100\u2013110. doi: 10.1016\/j.jns.2013.04.022","journal-title":"J Neurol Sci"},{"key":"820_CR19","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/j.1464-5491.2006.01916.x","volume":"23","author":"SC Lim","year":"2006","unstructured":"Lim SC, Goh SK, Lai YR et al (2006) Relationship between common functional polymorphisms of the p22phox gene (\u2212930A>G and +242C>T) and nephropathy as a result of Type 2 diabetes in a Chinese population. Diabet Med J Br Diabet Assoc 23:1037\u20131041. doi: 10.1111\/j.1464-5491.2006.01916.x","journal-title":"Diabet Med J Br Diabet Assoc"},{"key":"820_CR20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/(SICI)1096-8628(19990903)86:1<57::AID-AJMG11>3.0.CO;2-R","volume":"86","author":"A Li","year":"1999","unstructured":"Li A, Prasad A, Mincemoyer R et al (1999) Relationship of the C242T p22phox gene polymorphism to angiographic coronary artery disease and endothelial function. Am J Med Genet 86:57\u201361. doi: 10.1002\/(SICI)1096-8628(19990903)86:1<57:AID-AJMG11>3.0.CO;2-R","journal-title":"Am J Med Genet"},{"key":"820_CR21","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1053\/j.ajkd.2007.12.033","volume":"52","author":"Y Liu","year":"2008","unstructured":"Liu Y, Freedman BI, Burdon KP et al (2008) Association of arachidonate 12-lipoxygenase genotype variation and glycemic control with albuminuria in type 2 diabetes. Am J Kidney Dis Off J Natl Kidney Found 52:242\u2013250. doi: 10.1053\/j.ajkd.2007.12.033","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"key":"820_CR22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.atherosclerosis.2004.01.043","volume":"175","author":"Y Shimo-Nakanishi","year":"2004","unstructured":"Shimo-Nakanishi Y, Hasebe T, Suzuki A et al (2004) Functional effects of NAD(P)H oxidase p22(phox) C242T mutation in human leukocytes and association with thrombotic cerebral infarction. Atherosclerosis 175:109\u2013115. doi: 10.1016\/j.atherosclerosis.2004.01.043","journal-title":"Atherosclerosis"},{"key":"820_CR23","doi-asserted-by":"crossref","first-page":"30336","DOI":"10.1074\/jbc.M607191200","volume":"281","author":"Y Zhu","year":"2006","unstructured":"Zhu Y, Marchal CC, Casbon A-J et al (2006) Deletion mutagenesis of p22phox subunit of flavocytochrome b558: identification of regions critical for gp91phox maturation and NADPH oxidase activity. J Biol Chem 281:30336\u201330346. doi: 10.1074\/jbc.M607191200","journal-title":"J Biol Chem"},{"key":"820_CR24","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1677\/JME-07-0152","volume":"40","author":"M Xu","year":"2008","unstructured":"Xu M, Chen X, Yan L et al (2008) Association between (AC)n dinucleotide repeat polymorphism at the 5\u2032-end of the aldose reductase gene and diabetic nephropathy: a meta-analysis. J Mol Endocrinol 40:243\u2013251. doi: 10.1677\/JME-07-0152","journal-title":"J Mol Endocrinol"},{"key":"820_CR25","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.bbrc.2010.04.084","volume":"397","author":"Y Li","year":"2010","unstructured":"Li Y, Wang S (2010) Glycated albumin activates NADPH oxidase in rat mesangial cells through up-regulation of p47phox. Biochem Biophys Res Commun 397:5\u201311. doi: 10.1016\/j.bbrc.2010.04.084","journal-title":"Biochem Biophys Res Commun"},{"key":"820_CR26","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/sj.ki.5000147","volume":"69","author":"LF Quintana","year":"2006","unstructured":"Quintana LF, Guzm\u00e1n B, Collado S et al (2006) A coding polymorphism in the 12-lipoxygenase gene is associated to essential hypertension and urinary 12(S)-HETE. Kidney Int 69:526\u2013530. doi: 10.1038\/sj.ki.5000147","journal-title":"Kidney Int"},{"key":"820_CR27","author":"AS Krolewski","year":"2014","unstructured":"Krolewski AS, Gohda T, Niewczas MA (2014) Progressive renal decline as the major feature of diabetic nephropathy in type 1 diabetes. Clin Exp Nephrol. doi: 10.1007\/s10157-013-0900-y","journal-title":"Clin Exp Nephrol"},{"key":"820_CR28","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s11892-005-0055-7","volume":"5","author":"BA Perkins","year":"2005","unstructured":"Perkins BA, Krolewski AS (2005) Early nephropathy in type 1 diabetes: a new perspective on who will and who will not progress. Curr Diab Rep 5:455\u2013463","journal-title":"Curr Diab Rep"},{"key":"820_CR29","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.2337\/dc10-1170","volume":"33","author":"AM Secrest","year":"2010","unstructured":"Secrest AM, Becker DJ, Kelsey SF et al (2010) All-cause mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes: the Allegheny County type 1 diabetes registry. Diabetes Care 33:2573\u20132579. doi: 10.2337\/dc10-1170","journal-title":"Diabetes Care"},{"key":"820_CR30","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/humu.21029","volume":"30","author":"K Bedard","year":"2009","unstructured":"Bedard K, Attar H, Bonnefont J et al (2009) Three common polymorphisms in the CYBA gene form a haplotype associated with decreased ROS generation. Hum Mutat 30:1123\u20131133. doi: 10.1002\/humu.21029","journal-title":"Hum Mutat"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-015-0820-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00592-015-0820-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-015-0820-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T10:00:44Z","timestamp":1559124044000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00592-015-0820-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,25]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["820"],"URL":"https:\/\/doi.org\/10.1007\/s00592-015-0820-2","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"value":"0940-5429","type":"print"},{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,25]]}}}